CASE COMMENTS: FOREIGN CASE LAW - PUBLIC ENFORCEMENT – REGULATED MARKET – PHARMACEUTICAL SECTOR

Regulated sectors: The Swiss Federal Administrative Court declares that the Swiss Cartel Act does not apply to certain prescription drugs that are not covered by health insurance (Pfizer, Eli Lilly, Bayer)

KEYWORDS

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Federal Administrative Court, Judgments of 3 December 1013, Pfizer, Eli Lilly (Switzerland), Bayer (Schweiz) v. Competition Commission, B-364/2010, B-362/2010 and B-360/2010, DPC

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.

PDF Version

Author

Quotation

Pranvera Këllezi, Regulated sectors: The Swiss Federal Administrative Court declares that the Swiss Cartel Act does not apply to certain prescription drugs that are not covered by health insurance (Pfizer, Eli Lilly, Bayer) , 3 December 2013, Concurrences N° 2-2014, Art. N° 66054, p. 218

Visites 118

All reviews